Targeted Cancer Therapy

Recently, Professor Jeremiah A. Johnson from the Massachusetts Institute of Technology and his research team proposed a targeted cancer therapy using antibody–bottlebrush prodrug conjugates(Antibody-Bottlebrush Prodrug Conjugates, ABC). This research was published in the international academic journal Nature Biotechnology on September 9, 2025. A summary of this article and expert/editorial opinions were also published in the … Read more